Tetrapeptide caspase inhibitors exhibit protease- and substrate-dependent off-target specificity
En palabras de los autores
Peptide-based caspase inhibitors are widely used to define the functions of individual caspases and were developed from tetrapeptide substrate preferences identified using positional scanning peptide libraries. Their specificity is typically validated using fluorogenic tetrapeptide substrates, yet whether these assays accurately predict inhibition of endogenous protein substrates has not been systematically examined. Here, we demonstrate that the widely used executioner caspase inhibitor zDEVD-FMK directly inhibits caspase-1 (CASP1)-mediated processing of interleukin-1{beta} (IL-1{beta}) and interleukin-18 (IL-18) despite CASP1 exhibiting minimal activity toward the DEVD fluorogenic substrate. Unexpectedly, zDEVD-FMK selectively inhibited CASP1 but not the closely related inflammatory caspases CASP4 or CASP5. Conversely, the CASP1 inhibitor Ac-YVAD-CMK directly inhibited CASP3-mediated protein substrate cleavage. We further found that endogenous substrates displayed markedly different sensitivities to inhibition, with IL-1{beta} and IL-18 processing consistently inhibited more efficiently than gasdermin D cleavage, while fluorogenic CASP3/7 reporter cleavage substantially overestimated inhibition of endogenous apoptotic substrates. During inflammasome activation and Salmonella infection, DEVD- and YVAD-based inhibitors failed to distinguish apoptotic executioner caspase activity from inflammatory caspase signaling. Together, our findings demonstrate that fluorogenic tetrapeptide assays do not faithfully predict inhibition of endogenous protein substrates and identify protease- and substrate-dependent specificity as fundamental features of peptide-based caspase inhibitors.
Apareció: miércoles, 18 de noviembre. bioRxiv. Preprint, todavía sin revisión por pares.